What is Applied Science?
Applied Science is a dedicated healthcare solutions provider focused on pioneering innovations within the blood collection industry and chronic care management. At the heart of its offerings is the HemoFlow platform, engineered to automate whole blood collection processes. This automation not only optimizes donation procedures but also significantly enhances phlebotomist productivity, while simultaneously reducing errors and providing valuable operational intelligence. Complementing this, the AdaptivMD platform addresses the critical need for remote patient monitoring and effective chronic care management, with a strategic emphasis on value-based care models tailored for underserved populations. The company's success is further evidenced by its robust customer retention rates and an unwavering commitment to advancing health equity through strategic partnerships with healthcare providers.
How much funding has Applied Science raised?
Applied Science has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Applied Science
PPP
Public-Private Partnership
What's next for Applied Science?
With substantial backing and a clear strategic direction, Applied Science is poised for accelerated growth. The recent large-scale, late-stage funding indicates a focus on scaling operations, expanding market reach, and potentially further developing its HemoFlow and AdaptivMD platforms. Future initiatives are likely to concentrate on solidifying its position in the blood collection automation market and broadening the impact of its chronic care management solutions, particularly within value-based healthcare frameworks. Continued investment in technology and strategic partnerships will be key to achieving its mission of improving patient care and health equity.
See full Applied Science company page
